New heat therapy for dry eyes could beat old warm compress routine
NCT ID NCT03767530
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares a clinic-based thermal device (MiBo Thermoflo) to standard warm compresses for treating dry eye caused by meibomian gland dysfunction. About 42 adults who haven't improved with warm compresses will be randomly assigned to either three sessions of MiBo therapy or continued warm compresses. Researchers will measure eye surface health, tear quality, and symptoms over 24 weeks to see which approach works better.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEIBOMIAN GLAND DYSFUNCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Departamento de Oftalmologia, Hospital Universitario "Dr. Jose Eleuterio Gonzalez"
RECRUITINGMonterrey, Nuevo León, 64460, Mexico
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Dry eye showdown: light therapy vs warm compress – but study never started
- Can a nasal spray soothe dry eyes? new study investigates
- Can radio waves zap dry eye away? new trial tests device for stubborn cases
- Warm compresses vs. High-Tech eye gadgets: which best treats dry eye?
- Shedding light on dry eye: new study tests IPL and LED mask therapies
- Warm compress device shows promise for dry eyes before cataract surgery